Table 3.

Participant's treatment at assessment. Values are numbers (percentages) of participants

Treatment	Home care (n=100)	Hospital care (n=50)
Inhaled β agonist	94 (94)	45 (90)
Inhaled anticholinergic	53 (53)	31 (62)
Inhaled corticosteroid	75 (75)	42 (84)
Oral corticosteroid	36 (36)	19 (38)
Antibiotic	56 (56)	19 (38)
Nebulised bronchodilators	29 (29)	11 (22)
Theophylline	23 (23)	10 (20)
Long acting inhaled β agonist	18 (18)	10 (20)
Oxygen cylinder	10 (10)	6 (12)
Long term oxygen therapy	4 (4)	3 (6)